| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0295480456086947 | 0.19398574 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.0295480456086947 | 0.093127268 |
| NSC 13484 | Null | 0.0295480456086947 | 0.24632535 |
| NSC 168516 | Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | 0.0295480456086947 | 0.050743462 |
| NSC 287069 | Epicorazine A | 0.0295480456086947 | 0.10062603 |
| NSC 319947 | 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- | 0.0295480456086947 | 0.36392704 |
| NSC 618857 | 4-Piperidinone, 3,5-bis[[(4-methylthio)phenyl]methylene]-, hydrochloride | 0.0303322639291194 | 0.2146877 |
| NSC 621486 | 2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- | 0.0303322639291194 | -0.07288539 |
| NSC 627371 | 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- | 0.0303322639291194 | 0.013768602 |
| NSC 639505 | Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride | 0.0303322639291194 | 0.23157706 |